Intravitreal bevacizumab for treatment of choroidal neovascularization associated with osteogenesis imperfecta

Intravitreal bevacizumab for treatment of choroidal neovascularization associated with osteogenesis imperfecta

A 12-year-old girl, diagnosed of osteogenesis imperfecta, presented with sudden visual loss in the left eye. Investigations revealed an active choroidal neovascular membrane. She underwent treatment with intravitreal Bevacizumab (1.25 mg/0.05 ml). Follow-up at 1 month revealed the development of lac...

Full description

Bibliographic Details
Main Authors: Pukhraj Rishi, Ekta Rishi, Anusha Venkatraman
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2012-01-01
Series:Indian Journal of Ophthalmology
Subjects:
Plateau iris
primary angle closure glaucoma
prevalence
Enucleation
India
indications
trends
Closure glaucoma
primary angle
scanning electron microscopy
trabecular
Apoptosis
caspase-3/7
cigarette smoke toxicant
hydroquinone
Blepharophimosis
cosmetic
functional
single stage
Refractive error
rural area
school children
use of spectacles
Bietti′s crystalline dystrophy
choroidal neovascular membrane
ranibizumab
Blepharoptosis
epidermal cyst
excision
eyelid
AcrySof SN60T9
cataract
phacoemulsification
post-keratoplasty astigmatism
toric intraocular lens
Magnetic resonance imaging
optic neuritis
sphenoid sinus mucocele
visual evoked response
Cartridge tip
descemet′s tear
intraocular Lens
Allergy
cyclosporine
vernal keratoconjunctivitis
Endophthalmitis
limbal relaxing incision
nocardia
Ivermectin
lid laceration
orbital myiasis
scalp pediculosis
Conjunctiva
dipetalonema
worm
Bevacizumab
choroidal neovascularization
lacquer crack
osteogenesis imperfecta
Online Access:http://www.ijo.in/article.asp?issn=0301-4738;year=2012;volume=60;issue=3;spage=229;epage=231;aulast=Rishi

Internet

http://www.ijo.in/article.asp?issn=0301-4738;year=2012;volume=60;issue=3;spage=229;epage=231;aulast=Rishi

Similar Items